Aposense

Aposense is an Israeli biotechnology company which was established in 1996. Their main aim is to develop a proprietary platform technology that is based on membrane-related cellular processes. Aposense try to improve patient care. What concern of their technology, they target at the electrical potential map of cell membrane what is used in gene and drug delivery, molecular imaging and optimization of drug pharmacokinetic profile. Moreover, they are building proprietary Molecular Nano-Motors (MNM) capable of moving within the core of the cell membrane. The MNM are chemically linked to a drug of interest and used to improve drug delivery and performance.